Track cost pressure
Identify presentations with rising spend and create intervention plans focused on switching opportunities or formulary alignment.
BNF presentation directory
Explore British National Formulary presentations, drill into dispensing trend data, and identify which pharmacies drive the greatest usage of each medicine.
Active filters
- Product: Abilify
| Presentation | Product | Chemical substance | Chapter | Items dispensed |
|---|---|---|---|---|
|
Abilify 10mg tablets
0402010ADBBAAAA
|
Abilify | Aripiprazole | Central Nervous System | 1,085 |
|
Abilify 5mg tablets
0402010ADBBADAD
|
Abilify | Aripiprazole | Central Nervous System | 813 |
|
Abilify 15mg tablets
0402010ADBBABAB
|
Abilify | Aripiprazole | Central Nervous System | 456 |
|
Abilify 1mg/ml oral solution
0402010ADBBAGAG
|
Abilify | Aripiprazole | Central Nervous System | 139 |
|
Abilify 30mg tablets
0402010ADBBACAC
|
Abilify | Aripiprazole | Central Nervous System | 56 |
|
Abilify 10mg orodispersible tablets
0402010ADBBAEAE
|
Abilify | Aripiprazole | Central Nervous System | 23 |
|
Abilify 15mg orodispersible tablets
0402010ADBBAFAF
|
Abilify | Aripiprazole | Central Nervous System | 21 |
|
Abilify 9.75mg/1.3ml solution for injection vials
0402010ADBBAHAH
|
Abilify | Aripiprazole | Central Nervous System | No data available |
Why monitor BNF codes?
Link medicine usage to pharmacy and prescriber behaviour to find optimisation opportunities.
Understand demand drivers
Cross-reference high-volume medicines with local health priorities and prescriber activity to target support programs.